Zenphia · Life Sciences Commercialization

From Lab to Venture —
We Build the Infrastructure
That Turns Science into Companies.

Institutional infrastructure for building biotechnology companies. Advanced therapeutics · Institutional partnerships · Structured venture creation.

44
Years of Pattern Recognition
6
Integrated Capabilities
$54.5B
Market by 2030
97%
Of Research Never Reaches Patients

The Infrastructure That Takes Life Sciences Breakthroughs from Lab to Market.

The Ecosystem Is Broken by Design

97% of life sciences research never reaches patients — not because the science fails, but because the infrastructure around it does. IP strategy is misaligned with regulatory timelines. Clinical trials launch before safety systems exist. Leadership is deployed at the wrong phase. Capital is raised before the foundation exists to use it.

Most life sciences companies hire five to seven disconnected specialists who make critical decisions in silos. The result is predictable: FDA delays, wasted capital, and breakthrough therapies that never reach the people who need them.

Zenphia was built to fix that.

97%

of life sciences research never reaches patients — not because the science fails, but because execution infrastructure is assembled wrong.

IP Strategy ≠ Regulatory
Clinical ≠ Product Dev
Leadership ≠ Phase
Capital ≠ Infrastructure
Formation ≠ Strategy
5–7 Disconnected Firms

Six Integrated Capabilities.
One Partner.

Most competitors offer one or two. Zenphia delivers all six — integrated, sequenced, and deployed upstream before structural mistakes become irreversible. We are not a consulting firm. We are the system that makes both work.

01
IP Strategy & Portfolio Management

Patent prosecution, FTO analysis, licensing vs. equity pathways — all informed by regulatory timelines.

02
Clinical & Regulatory Strategy

FDA pathway design pre-IND through approval, IND/NDA submissions, pharmacovigilance.

03
Medical Product Development

Device concept through FDA clearance, design for manufacturing, prototyping — integrated from Day 1.

04
Scientific Strategy & Translational Medicine

Clinical-stage biotech development, translational research commercialization, venture creation.

05
Leadership Architecture & Deployment

44 years placing C-suite talent. Governance designed before talent is deployed — not after.

06
Venture Creation Studio

Performance-contingent company building with equity participation from formation through seed stage.

Ready to Build Something That Lasts?

Partner with Zenphia to build biotechnology's future. Whether you're a research institution, investor, or biotech company, we're here to help.

Schedule Consultation